Abstract
A recent meta-analysis suggests an association between the rs11558538 single nucleotide polymorphism in the histamine-N-methyl-transferase (HNMT) gene and the risk for Parkinson’s disease. Based on the possible relationship between PD and restless legs syndrome (RLS), we tried to establish whether rs11558538 SNP is associated with the risk for RLS. We studied the genotype and allelic variant frequencies of HNMT rs11558538 SNP 205 RLS patients and 410 healthy controls using a TaqMan assay. The frequencies of the HNMT rs11558538 genotypes allelic variants were similar between RLS patients and controls, and were not influenced by gender, family history of RLS, or RLS severity. RLS patients carrying the genotype rs11558538TT had an earlier age at onset, but this finding was based on three subjects only. These results suggest a lack of major association between HNMT rs11558538 SNP and the risk for RLS.
Similar content being viewed by others
References
Alfaro-Rodriguez A, Alonso-Spilsbury M, Arch-Tirado E, Gonzalez-Pina R, Arias-Montaño JA, Bueno-Nava A (2013) Histamine H3 receptor activation prevents dopamine D1 receptor-mediated inhibition of dopamine release in the rat striatum: a microdialysis study. Neurosci Lett 552:5–9
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J, Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health, International Restless Legs Syndrome Study Group (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology work shop at the National Institute of Health. Sleep Med 4:101–119
Allen RP, Lesage S, Earley CJ (2005) Anti-histamines and benzodiazepines exacerbate daytime restless legs syndrome symptoms. Sleep 28:279 (abstract)
Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study Group (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria—history, rationale, description, and significance. Sleep Med 15:860–873
Altman DG, Bland JM (1994) Diagnostic tests 2: predictive values. BMJ 309:102
Bliwise DL, Zhang RH, Kutner NG (2014) Medications associated with restless legs syndrome: a case-control study in the US Renal Data System (USRDS). Sleep Med 15:1241–1245
Dringenberg HC, de Souza-Silva MA, Schwarting RK, Huston JP (1998) Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade. Naunyn Schmiedebergs Arch Pharmacol 358:423–429
Ellenbroek BA (2013) Histamine H3 receptors, the complex interaction with dopamine and its implications for addiction. Br J Pharmacol 170:46–57
Ferrada C, Ferré S, Casadó V, Cortés A, Justinova Z, Barnes C, Canela EI, Goldberg SR, Leurs R, Lluis C, Franco R (2008) Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 55:190–197
Flik G, Folgering JH, Cremers TI, Westerink BH, Dremencov E (2015) Interaction between brain histamine and serotonin, norepinephrine, and dopamine systems. In vivo microdialysis and electrophysiology study. J Mol Neurosci 56:320–328
Gao X, Schwarzschild MA, O’Reilly EJ, Wang H, Ascherio A (2010) Restless legs syndrome and Parkinson’s disease in men. Mov Disord 25:2654–2657
García Martín E, Martínez C, Serrador M, Alonso-Navarro H, Ayuso P, Navacerrada F, Agúndez JA, Jiménez-Jiménez FJ (2015) Diamine oxidase rs10156191 and rs2052129 variants are associated with the risk for migraine. Headache 55:276–286
García-Martín E, Ayuso P, Martínez C, Blanca M, Agúndez JA (2009) Histamine pharmacogenomics. Pharmacogenomics 10:867–883
García-Martín E, Martínez C, Benito-León J, Calleja P, Díaz-Sánchez M, Pisa D, Alonso-Navarro H, Ayuso-Peralta L, Torrecilla D, Agúndez JA, Jiménez-Jiménez FJ (2010) Histamine-N-methyl transferase polymorphism and risk for multiple sclerosis. Eur J Neurol 17:335–338
García-Martín E, Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Ortega-Cubero S, Pastor P, Calleja M, Plaza-Nieto JF, Pilo-de-la-Fuente B, Arroyo-Solera M, García-Albea E, Agúndez JA (2015) Heme oxygenase-1 and 2 common genetic variants and risk for restless legs syndrome. Medicine (Baltimore) 94:e1448
Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JA (2013) Latest perspectives in genetic risk factors for restless legs syndrome. Eur Neurol Rev 8:90–96. http://www.touchneurology.com/articles/latest-perspectives-genetic-risk-factors-restless-legs-syndrome. Accessed 25 Sept 2016
Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JA (2015) Neurochemistry of idiopathic restless legs syndrome. Eur Neurol Rev 10: 35–44. http://www.touchneurology.com/articles/neurochemistry-idiopathic-restless-legs-syndrome. Accessed 25 Sept 2016
Jiménez-Jiménez FJ, García-Martín E, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Ortega-Cubero S, Pastor P, Calleja M, Plaza-Nieto JF, Pilo-De-La-Fuente B, Arroyo-Solera M, García-Albea E, Agúndez JA (2015b) Association between vitamin d receptor rs731236 (Taq1) polymorphism and risk for restless legs syndrome in the spanish caucasian population. Medicine (Baltimore) 94:e2125
Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JA (2016) Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for Parkinson’s disease: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 95:e4147
Kubota Y, Ito C, Sakurai E, Sakurai E, Watanabe T, Ohtsu H (2002) Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. J Neurochem 83:837–845
Ledesma MC, García-Martín E, Alonso-Navarro H, Martínez C, Jiménez-Jiménez FJ, Benito-León J, Puertas I, Rubio L, López-Alburquerque T, Agúndez JA (2008) The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor. Neuromol Med 10:356–361
Lee HS, Kim SH, Kim KW, Baek JY, Park HS, Lee KE, Hong JY, Kim MN, Heo WI, Sohn MH, Kim KE (2012) Involvement of human histamine N-methyltransferase gene polymorphisms in susceptibility to atopic dermatitis in korean children. Allergy Asthma Immunol Res 4:31–36
Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, Lee JH, Cheng R, International Parkinson’s Disease Genomics Consortium (IPDGC), Parkinson’s Study Group (PSG) Parkinson’s Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Ashkenazi Jewish Dataset Investigator, Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE), North American Brain Expression Consortium (NABEC), United Kingdom Brain Expression Consortium (UKBEC), Greek Parkinson’s Disease Consortium, Alzheimer Genetic Analysis Group, Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet 46:989–993
Oroszi G, Enoch MA, Chun J, Virkkunen M, Goldman D (2005) Thr105Ile, a functional polymorphism of histamine N-methyltransferase, is associated with alcoholism in two independent populations. Alcohol Clin Exp Res 29:303–309
O’Sullivan RL, Greenberg DB (1993) H2 antagonists, restless leg syndrome and movement disorders. Psychosomatics 34:530–532
Panula P, Yang HY, Costa E (1984) Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 81:2572–2576
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575
Reuter M, Jeste N, Klein T, Hennig J, Goldman D, Enoch MA, Oroszi G (2007) Association of Thr105Ile, a functional polymorphism of histamine N-methyltransferase (HNMT), with alcoholism in German Caucasians. Drug Alcohol Depend 87:69–75
Sánchez-Lemus E, Arias-Montaño JA (2004) Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices. Neurosci Lett 364:179–184
Szczepankiewicz A, Bręborowicz A, Sobkowiak P, Popiel A (2010) Polymorphisms of two histamine-metabolizing enzymes genes and childhood allergic asthma: a case control study. Clin Mol Allergy 8:14
Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C, International Restless Legs Syndrome Study Group (2003) Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 4:121–132
Wang L, Thomae B, Eckloff B, Wieben E, Weinshilboum R (2002) Human histamine N-methyltransferase pharmacogenetics: gene resequencing, promoter characterization, and functional studies of a common 5′-flanking region single nucleotide polymorphism (SNP). Biochem Pharmacol 64:699–710
Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y, Tohyama M, Wada H (1984) Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 295:13–25
Wong JC, Li Y, Schwarzschild MA, Ascherio A, Gao X (2014) Restless legs syndrome: an early clinical feature of Parkinson disease in men. Sleep 37:369–372
Yan L, Galinsky RE, Bernstein JA, Liggett SB, Weinshilboum RM (2000) Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. Pharmacogenetics 10:261–266
Acknowledgements
This work was supported in part by Grants PI12/00241, PI12/00324, PI15/00303, and RETICS RD12/0013/0002 from Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Madrid, Spain; GR15026 from Junta de Extremadura, Mérida, Spain; PRIS10016 (Fundesalud, Mérida,Spain); grants from the Spanish Ministry of Science and Innovation SAF2006-10126 (2006-2009) and SAF2010-22329-C02-01 (2011-2013) to P.P and by the “Unión Técnica de Empresas” (UTE) project FIMA to P.P. and project from the Centro de Investigaciones Médicas Aplicadas (CIMA), Spain. The study was partially funded by FEDER funds.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors reported any conflicts of interest.
Rights and permissions
About this article
Cite this article
Jiménez-Jiménez, F.J., García-Martín, E., Alonso-Navarro, H. et al. Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for restless legs syndrome. J Neural Transm 124, 285–291 (2017). https://doi.org/10.1007/s00702-016-1645-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-016-1645-z